Literature DB >> 26898316

Cross-Reactivity among Beta-Lactams.

Antonino Romano1,2, Francesco Gaeta3, Maria Francisca Arribas Poves4, Rocco Luigi Valluzzi3.   

Abstract

Penicillins and cephalosporins are the major classes of beta-lactam (BL) antibiotics in use today and one of the most frequent causes of hypersensitivity reactions to drugs. Monobactams, carbapenems, oxacephems, and beta-lactamase inhibitors constitute the four minor classes of BLs. This review takes into account mainly the prospective studies which evaluated cross-reactivity among BLs in subjects with a well-demonstrated hypersensitivity to a certain class of BLs by performing allergy tests with alternative BLs and, in case of negative results, administering them. In subjects with either IgE-mediated or T-cell-mediated hypersensitivity, cross-reactivity among BLs, particularly among penicillins and among cephalosporins, as well as between penicillins and cephalosporins, seems to be mainly related to structural similarities among their side-chain determinants. Specifically, in penicillin-allergic subjects, cross-reactivity between penicillins and cephalosporins may exceed 30% when they are administered cephalosporins with identical side chains to those of responsible penicillins. In these subjects, a few prospective studies have demonstrated a rate of cross-reactivity between penicillins and both carbapenems and aztreonam lower than 1%. With regard to subjects with an IgE-mediated hypersensitivity to cephalosporins, in a single study, about 25% of the 98 subjects with such hypersensitivity had positive results to penicillins, 3% to aztreonam, 2% to imipenem/cilastatin, and 1% to meropenem. The cross-reactivity related to the selective recognition of the BL ring by IgE or T lymphocytes, which entails positive responses to all BLs tested, appears to be exceptional. Some studies concerning cross-reactivity among BLs have found patterns of allergy-test positivity which cannot be explained by either the common BL ring or by similar or identical side chains, thus indicating the possibility of coexisting sensitivities to different BLs because of prior exposures to them.

Entities:  

Keywords:  Aztreonam; Beta-lactams; Carbapenems; Cephalosporins; Cross-reactivity; Hypersensitivity; Penicillins

Mesh:

Substances:

Year:  2016        PMID: 26898316     DOI: 10.1007/s11882-016-0594-9

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  61 in total

1.  Diagnosing nonimmediate reactions to cephalosporins.

Authors:  Antonino Romano; Francesco Gaeta; Rocco Luigi Valluzzi; Cristiano Caruso; Cristiana Alonzi; Marinella Viola; Philippe Jean Bousquet
Journal:  J Allergy Clin Immunol       Date:  2012-02-08       Impact factor: 10.793

2.  Imipenem in patients with immediate hypersensitivity to penicillins.

Authors:  Antonino Romano; Marinella Viola; Rosa-Maria Guéant-Rodriguez; Francesco Gaeta; Rosa Pettinato; Jean-Louis Guéant
Journal:  N Engl J Med       Date:  2006-06-29       Impact factor: 91.245

3.  Lack of allergic cross-reactivity to cephalosporins among patients allergic to penicillins.

Authors:  A Novalbos; J Sastre; J Cuesta; M De Las Heras; M Lluch-Bernal; C Bombín; S Quirce
Journal:  Clin Exp Allergy       Date:  2001-03       Impact factor: 5.018

4.  Immediate allergic reactions to cephalosporins: cross-reactivity and selective responses.

Authors:  A Romano; C Mayorga; M J Torres; M C Artesani; R Suau; F Sánchez; E Pérez; A Venuti; M Blanca
Journal:  J Allergy Clin Immunol       Date:  2000-12       Impact factor: 10.793

5.  Delayed allergy to aminopenicillins: clinical and immunological findings.

Authors:  D Schiavino; E Nucera; T De Pasquale; C Roncallo; E Pollastrini; C Lombardo; L Giuliani; L M Larocca; A Buonomo; G Patriarca
Journal:  Int J Immunopathol Pharmacol       Date:  2006 Oct-Dec       Impact factor: 3.219

6.  Allergic reactions to betalactams: studies in a group of patients allergic to penicillin and evaluation of cross-reactivity with cephalosporin.

Authors:  M Audicana; G Bernaola; I Urrutia; S Echechipia; G Gastaminza; D Muñoz; E Fernández; L Fernández de Corres
Journal:  Allergy       Date:  1994-02       Impact factor: 13.146

7.  Immediate allergic reactions to cephalosporins: evaluation of cross-reactivity with a panel of penicillins and cephalosporins.

Authors:  Cristina Antunez; Natalia Blanca-Lopez; Maria Jose Torres; Cristobalina Mayorga; Ezequiel Perez-Inestrosa; Maria Isabel Montañez; Tahia Fernandez; Miguel Blanca
Journal:  J Allergy Clin Immunol       Date:  2006-02       Impact factor: 10.793

8.  Evaluation of adverse cutaneous reactions to aminopenicillins with emphasis on those manifested by maculopapular rashes.

Authors:  A Romano; M Di Fonso; G Papa; F Pietrantonio; F Federico; G Fabrizi; A Venuti
Journal:  Allergy       Date:  1995-02       Impact factor: 13.146

9.  beta-Lactam allergenic determinants: fine structural recognition of a cross-reacting determinant on benzylpenicillin and cephalothin.

Authors:  Z Zhao; B A Baldo; J Rimmer
Journal:  Clin Exp Allergy       Date:  2002-11       Impact factor: 5.018

10.  Sensitization to aztreonam and cross-reactivity with other beta-lactam antibiotics in high-risk patients with cystic fibrosis.

Authors:  R B Moss
Journal:  J Allergy Clin Immunol       Date:  1991-01       Impact factor: 10.793

View more
  24 in total

Review 1.  Antibiotic Allergy in Pediatrics.

Authors:  Allison Eaddy Norton; Katherine Konvinse; Elizabeth J Phillips; Ana Dioun Broyles
Journal:  Pediatrics       Date:  2018-05       Impact factor: 7.124

Review 2.  Controversies in Drug Allergy: Drug Allergy Pathways.

Authors:  Anca M Chiriac; Aleena Banerji; Rebecca S Gruchalla; Bernard Y H Thong; Paige Wickner; Paul-Michel Mertes; Ingrid Terreehorst; Kimberly G Blumenthal
Journal:  J Allergy Clin Immunol Pract       Date:  2018-12-17

Review 3.  The Current State of Antimicrobial Stewardship: Challenges, Successes, and Future Directions.

Authors:  Jennifer Emberger; Dan Tassone; Michael P Stevens; J Daniel Markley
Journal:  Curr Infect Dis Rep       Date:  2018-06-29       Impact factor: 3.725

Review 4.  The 3 Cs of Antibiotic Allergy-Classification, Cross-Reactivity, and Collaboration.

Authors:  Jason A Trubiano; Cosby A Stone; M Lindsay Grayson; Karen Urbancic; Monica A Slavin; Karin A Thursky; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2017-08-23

Review 5.  The challenge of de-labeling penicillin allergy.

Authors:  Cosby A Stone; Jason Trubiano; David T Coleman; Christine R F Rukasin; Elizabeth J Phillips
Journal:  Allergy       Date:  2019-05-26       Impact factor: 13.146

Review 6.  Immediate and Delayed Hypersensitivity Reactions to Beta-Lactam Antibiotics.

Authors:  Ellen Minaldi; Elizabeth J Phillips; Allison Norton
Journal:  Clin Rev Allergy Immunol       Date:  2021-11-12       Impact factor: 8.667

7.  How antibiotic allergy labels may be harming our most vulnerable patients.

Authors:  Jason A Trubiano; M Lindsay Grayson; Karin A Thursky; Elizabeth J Phillips; Monica A Slavin
Journal:  Med J Aust       Date:  2018-06-18       Impact factor: 7.738

8.  A General LC-MS/MS Method for Monitoring Potential β-Lactam Contamination in Drugs and Drug-Manufacturing Surfaces.

Authors:  Chen Qiu; Hongbin Zhu; Connie Ruzicka; David Keire; Hongping Ye
Journal:  AAPS J       Date:  2018-05-15       Impact factor: 4.009

9.  Testing Strategies and Predictors for Evaluating Immediate and Delayed Reactions to Cephalosporins.

Authors:  Cosby A Stone; Jason A Trubiano; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2020-08-19

10.  Beta-lactam-induced immediate hypersensitivity reactions: A genome-wide association study of a deeply phenotyped cohort.

Authors:  Paola Nicoletti; Daniel F Carr; Sarah Barrett; Laurence McEvoy; Peter S Friedmann; Neil H Shear; Matthew R Nelson; Anca M Chiriac; Natalia Blanca-López; José A Cornejo-García; Francesco Gaeta; Alla Nakonechna; Maria J Torres; Cristiano Caruso; Rocco L Valluzzi; Aris Floratos; Yufeng Shen; Rebecca K Pavlos; Elizabeth J Phillips; Pascal Demoly; Antonino Romano; Miguel Blanca; Munir Pirmohamed
Journal:  J Allergy Clin Immunol       Date:  2020-10-13       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.